GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
SF Assemblymember Matt Haney asked the state attorney general to investigate a lack of street trees, despite the city’s homelessness, drug and housing crises....
https://www.axios.com/2026/01/17/federal-judge-limits-ice-minnesota-metro-surge...
The illiterate "Burberry Bandit" -- whose well-dressed robberies made past headlines -- was nabbed yet again for trying to knock off a half-dozen banks across Manhattan, the feds said Friday....
